vVARDIS Holding AG(VVVV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.28 | Insider Own | - | Shs Outstand | 20.5M | Perf Week | -11.82% |
| Market Cap | 0.58B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | - |
| Enterprise Value | 0.69B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | - |
| Income | -0.05B | P/S | 11.6 | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | 0.05B | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | 3.93% |
| Book/sh | -5.72 | P/C | 19.89 | EPS past 3/5Y | - | ROE | - | 52W High | -14.16% ($16.95) | Perf Year | - |
| Cash/sh | 0.73 | P/FCF | - | Sales past 3/5Y | - | ROIC | -509.36% | 52W Low | 3.93% ($14.00) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | 76.46% | Volatility(W/M) | 4.79% - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 13.91 | Sales Y/Y TTM | - | Oper. Margin | -71.56% | ATR (14) | 1.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.7 | EPS Q/Q | 24.73% | Profit Margin | -105.16% | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.92 | Sales Q/Q | 214.24% | SMA20 | -6.45% ($15.55) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -6.45% ($15.55) | Rel Volume | 0.31 | Prev Close | $15 |
| Employees | 137 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -6.45% ($15.55) | Avg Volume(3M) | 1.09M | Price | $14.55 |
| IPO | 2026/11/13 | Option/Short | No/Yes | Trades | 939 | Volume | 341,540 | Change | -3% |
A Swiss medtech company developing biomimetic dental solutions that treat early-stage cavities without the use of drills. The company focuses on early caries treatment, oral care, and whitening products, with its Curodont product line serving as its flagship in the US market. It is expanding its business through two channels: dental offices and consumer oral care.
Over the past 1 year, on the lower side
14% below its 1-year high.
Traded less than usual. That is 31% of its average volume.
VVVV has weak earning power
Of every $100 in sales, $71.56 is lost.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1,160. Peers typically go for $284.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Shareholder Composition Guide
Tap to view numbers
It ranks #29 of 52 in the industry
Based on market cap of $576M.
FAQ
VVVV belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
The market cap of VVVV is approximately $576M, ranking 2,910 within its sector.
VVVV has recorded a 52-week high of $16.95 and a low of $14.00.